Edward J. Sitar
2014 - Cancer Genetics
In 2014, Edward J. Sitar earned a total compensation of $1.3M as Chief Financial Officer at Cancer Genetics.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Option Awards | $967,443 |
| Salary | $195,310 |
| Stock Awards | $117,000 |
| Total | $1,344,753 |
Sitar received $967.4K in option awards, accounting for 72% of the total pay in 2014.
Sitar also received $65K in bonus, $195.3K in salary and $117K in stock awards.
Rankings
In 2014, Edward J. Sitar's compensation ranked 6,268th out of 13,032 executives tracked by ExecPay. In other words, Sitar earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,268 out of 13,032 | 52nd |
Division Services | 1,055 out of 2,085 | 49th |
Major group Health Services | 109 out of 219 | 50th |
Industry group Medical And Dental Laboratories | 19 out of 56 | 66th |
Industry Medical Laboratories | 19 out of 56 | 66th |
Source: SEC filing on September 12, 2016.
Sitar's colleagues
We found two more compensation records of executives who worked with Edward J. Sitar at Cancer Genetics in 2014.